Chemomab Therapeutics Ltd DRC (CMMB) — Working Capital to Net Assets Ratio
Chemomab Therapeutics Ltd DRC (CMMB) has a Working Capital to Net Assets ratio of 96.8% as of June 2026. Working capital of $8.40 Million (current assets of $9.96 Million minus current liabilities of $1.55 Million) is measured against net assets of $8.68 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See Chemomab Therapeutics Ltd DRC defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Chemomab Therapeutics Ltd DRC Working Capital to Net Assets (2012–2025)
This chart shows how Chemomab Therapeutics Ltd DRC's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2012 to 2025. As of June 2026, the ratio stands at 96.8%, reflecting working capital of $8.40 Million against net assets of $8.68 Million USD. For the complete balance sheet picture, see CMMB total assets.
Annual Working Capital to Net Assets for Chemomab Therapeutics Ltd DRC (2012–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Chemomab Therapeutics Ltd DRC from 2012 to 2025, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Chemomab Therapeutics Ltd DRC (CMMB) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 96.9% | $11.95 Million | $12.33 Million | $13.42 Million | $1.48 Million | ▲ +2.1 pp |
| 2024 | 94.7% | $12.82 Million | $13.54 Million | $16.04 Million | $3.22 Million | ▲ +0.2 pp |
| 2023 | 94.5% | $16.06 Million | $17.00 Million | $20.90 Million | $4.84 Million | ▼ -2.1 pp |
| 2022 | 96.6% | $34.99 Million | $36.22 Million | $41.74 Million | $6.75 Million | ▼ -1.1 pp |
| 2021 | 97.7% | $60.04 Million | $61.47 Million | $62.69 Million | $2.65 Million | ▲ +0.3 pp |
| 2020 | 97.4% | $10.52 Million | $10.80 Million | $11.84 Million | $1.32 Million | ▲ +2.9 pp |
| 2019 | 94.5% | $14.09 Million | $14.91 Million | $18.21 Million | $4.12 Million | ▲ +11.1 pp |
| 2018 | 83.4% | $8.17 Million | $9.80 Million | $10.92 Million | $2.75 Million | ▼ -98.4 pp |
| 2017 | 181.8% | $-1.11 Million | $-609.00K | $1.59 Million | $2.70 Million | ▲ +105.5 pp |
| 2016 | 76.3% | $2.51 Million | $3.29 Million | $4.87 Million | $2.36 Million | ▼ -6.0 pp |
| 2015 | 82.3% | $1.76 Million | $2.14 Million | $3.10 Million | $1.33 Million | ▼ -47.4 pp |
| 2012 | 129.7% | $4.27 Million | $3.29 Million | $9.16 Million | $4.89 Million | — |